share_log

百利天恒(688506.SH)：收到8亿美元有关BL-B01D1项目首付款

Baili Tianheng (688506.SH): Received US$800 million down payment for BL-B01D1 project

Zhitong Finance ·  Mar 10 15:45

Zhitong Finance App News, Bailey Tianheng (688506.SH) announced that on December 11, 2023, SysTimMune, Inc.'s wholly-owned subsidiary SysTimMune, Inc. and Bristol-Myers Squibb (“BMS”, NYSE code: BMY) reached an exclusive license and cooperation agreement for the BL-B01D1 (EGFR×HER3 dual-antibody ADC) project. On February 8, 2024, the cooperation agreement officially came into effect.

As of March 7, 2024, the company has received a down payment of 800 million US dollars from BMS (the actual payment amount is subject to bank charges), and the company expects this payment to have a positive impact on the 2024 results.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment